&#xa0;
[normal]Written evidence submitted by [bold]John Innes Centre, Norwic[bold]h[bold] (AMR0030)[bold]&#xa0;[bold]Summary
[normal]&#xa0;
[normal]&#xa0;
[normal]Introduction to JIC
[normal]&#xa0;
[normal]&#xa0;[bold]&#xa0;[bold]Question 1: How has anti-microbial resistance developed in the last decade?
[normal]&#xa0;[bold]&#xa0;
[normal]Question 2: What are the gaps in our knowledge about antimicrobial resistance?
[normal]&#xa0;[bold]&#xa0;[bold]Question 3:  Is there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection?  If not, how could this be rectified?
[normal]&#xa0;[bold]&#xa0;
[normal]&#xa0;[bold]Question 4: What measures (including 
[normal]behavioural
[normal] change) have been most effective in controlling the spread of resistant pathogens, and could such measures be used to control other pathogens?
[normal]&#xa0;[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;[bold]Question 5: What global coordination and agreement is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives?
[normal]&#xa0;[bold]Question 6: What are the strengths and weaknesses of the Government's 2013-2018 strategy for tackling antimicrobial resistance?  What changes might be made to further strengthen the Government's action plan? 
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]November 2013
[normal]&#xa0;
[normal]